These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30062507)

  • 1. The role of radiation therapy in the treatment of metastatic cancer.
    Stea B; Skrepnik T; Hsu CC; Abendroth R
    Clin Exp Metastasis; 2018 Aug; 35(5-6):535-546. PubMed ID: 30062507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Radiosurgery for Treatment of Brain Metastases.
    Badiyan SN; Regine WF; Mehta M
    J Oncol Pract; 2016 Aug; 12(8):703-12. PubMed ID: 27511715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Qian JM; Yu JB; Kluger HM; Chiang VL
    Cancer; 2016 Oct; 122(19):3051-8. PubMed ID: 27285122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases.
    Lehrer EJ; McGee HM; Peterson JL; Vallow L; Ruiz-Garcia H; Zaorsky NG; Sharma S; Trifiletti DM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of radiation therapy in the management of cutaneous melanoma.
    Rao NG; Yu HH; Trotti A; Sondak VK
    Surg Oncol Clin N Am; 2011 Jan; 20(1):115-31. PubMed ID: 21111962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-brain radiation therapy for brain metastases: detrimental or beneficial?
    Gemici C; Yaprak G
    Radiat Oncol; 2015 Jul; 10():153. PubMed ID: 26215106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment.
    Zhang I; Formenti SC; Knisely JPS
    Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases.
    Khan M; Lin J; Liao G; Tian Y; Liang Y; Li R; Liu M; Yuan Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818798792. PubMed ID: 30213236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma.
    Caruso JP; Cohen-Inbar O; Bilsky MH; Gerszten PC; Sheehan JP
    Neurosurg Focus; 2015 Mar; 38(3):E6. PubMed ID: 25727228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosurgery and Immunotherapy in the Treatment of Brain Metastases.
    Ramakrishna R; Formenti S
    World Neurosurg; 2019 Oct; 130():615-622. PubMed ID: 31581411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.
    Moraes FY; Taunk NK; Marta GN; Suh JH; Yamada Y
    Oncologist; 2016 Feb; 21(2):244-51. PubMed ID: 26764249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery for cerebral metastatic melanoma.
    Somaza S; Kondziolka D; Lunsford LD; Kirkwood JM; Flickinger JC
    J Neurosurg; 1993 Nov; 79(5):661-6. PubMed ID: 8410244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Radiation in the Era of Effective Systemic Therapy for Melanoma.
    Wernicke AG; Polce S; Parashar B
    Surg Clin North Am; 2020 Feb; 100(1):189-199. PubMed ID: 31753112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies.
    Choong ES; Lo S; Drummond M; Fogarty GB; Menzies AM; Guminski A; Shivalingam B; Clarke K; Long GV; Hong AM
    Eur J Cancer; 2017 Apr; 75():169-178. PubMed ID: 28236768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation Therapy in the Management of Malignant Melanoma.
    Mahadevan A; Patel VL; Dagoglu N
    Oncology (Williston Park); 2015 Oct; 29(10):743-51. PubMed ID: 26470898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update.
    Park HS; Chiang VL; Knisely JP; Raldow AC; Yu JB
    Expert Rev Anticancer Ther; 2011 Nov; 11(11):1731-8. PubMed ID: 22050022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiation therapy of brain metastases from colorectal cancer: A single institution cohort.
    Paix A; Antoni D; Adeduntan R; Noël G
    Cancer Radiother; 2017 May; 21(3):199-204. PubMed ID: 28499660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.